Recipient toll-like receptors contribute to chronic graft dysfunction by both MyD88- and TRIF-dependent signaling

DMM Disease Models and Mechanisms

Volumn 3, Issue 1-2, 2010, Pages 92-103

  Wang, Shijun ^a   Schmaderer, Christoph ^a   Kiss, Eva ^a   Schmidt, Claudia ^a   Bonrouhi, Mahnaz ^a   Porubsky, Stefan ^a   Gretz, Norbert ^b   Schaefer, Liliana ^c   Kirschning, Carsten J ^d   Popovic, Zoran V ^a   Gröne, Hermann Josef ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c GOETHE UNIVERSITY   (Germany)

^d TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; ARGINASE 1; BIGLYCAN; BIOLOGICAL MARKER; CD4 ANTIGEN; CD8 ANTIGEN; COLLAGEN TYPE 1; COLLAGEN TYPE 3; CREATININE; FIBRINOGEN; GAMMA INTERFERON; GLUCOSE REGULATED PROTEIN 94; GLYCOPROTEIN P 15095; HEAT SHOCK PROTEIN 60; HIGH MOBILITY GROUP B1 PROTEIN; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 6; KI 67 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MONOCYTE CHEMOTACTIC PROTEIN 1; MYELOID DIFFERENTIATION FACTOR 88; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 1; UREA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BAGG ALBINO MOUSE; C3H MOUSE; C57BL 6 MOUSE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CHRONIC GRAFT REJECTION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; CREATININE URINE LEVEL; CYTOKINE RELEASE; DENDRITIC CELL; FLOW CYTOMETRY; GRAFT RECIPIENT; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; KIDNEY ALLOGRAFT REJECTION; KIDNEY FIBROSIS; KIDNEY TRANSPLANTATION; MACROPHAGE; MALE; MONONUCLEAR CELL; MOUSE; MOUSE MUTANT; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; UPREGULATION; UREA BLOOD LEVEL;

ADAPTOR PROTEINS, VESICULAR TRANSPORT; ANIMALS; CELL COUNT; CYTOKINES; FIBROSIS; GRAFT REJECTION; IMMUNOPHENOTYPING; KIDNEY; KIDNEY TRANSPLANTATION; LIGANDS; MICE; MYELOID DIFFERENTIATION FACTOR 88; ORGAN SPECIFICITY; PRIMARY GRAFT DYSFUNCTION; SIGNAL TRANSDUCTION; TIME FACTORS; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4; TRANSPLANTATION, HOMOLOGOUS;

ANIMALIA;

EID: 77649204540     PISSN: 17548403     EISSN: 17548411     Source Type: Journal    
DOI: 10.1242/dmm.003533     Document Type: Article

References (53)

1. Adams, J., Kiss, E., Arroyo, A. B., Bonrouhi, M., Sun, Q., Li, Z., Gretz, N., Schnitger, A., Zouboulis, C. C., Wiesel, M. et al. (2005). 13-cis retinoic acid inhibits development and progression of chronic allograft nephropathy. Am. J. Pathol. 167, 285-298.
2. Akira, S. and Takeda, K. (2004). Toll-like receptor signalling. Nat. Rev. Immunol. 4, 499-511.
3. Banas, M. C., Banas, B., Hudkins, K. L., Wietecha, T. A., Iyoda, M., Bock, E., Hauser, P., Pippin, J. W., Shankland, S. J., Smith, K. D. et al. (2008). TLR4 links podocytes with the innate immune system to mediate glomerular injury. J. Am. Soc. Nephrol. 19, 704-713.
4. Bedke, J., Kiss, E., Schaefer, L., Behnes, C. L., Bonrouhi, M., Gretz, N., Horuk, R., Diedrichs-Moehring, M., Wildner, G., Nelson, P. J. et al. (2007). Beneficial effects of CCR1 blockade on the progression of chronic renal allograft damage. Am. J. Transplant. 7, 527-537.
5. Bennett-Guerrero, E., Grocott, H. P., Levy, J. H., Stierer, K. A., Hogue, C. W., Cheung, A. T., Newman, M. F., Carter, A. A., Rossignol, D. P. and Collard, C. D. (2007). A phase II, double-blind, placebo-controlled, ascending-dose study of Eritoran (E5564), a lipid A antagonist, in patients undergoing cardiac surgery with cardiopulmonary bypass. Anesth. Analg. 104, 378-383.
6. Cavassani, K. A., Ishii, M., Wen, H., Schaller, M. A., Lincoln, P. M., Lukacs, N. W., Hogaboam, C. M. and Kunkel, S. L. (2008). TLR3 is an endogenous sensor of tissue necrosis during acute inflammatory events. J. Exp. Med. 205, 2609-2621.
7. Chow, F. Y., Nikolic-Paterson, D. J., Ozols, E., Atkins, R. C., Rollin, B. J. and Tesch, G. H. (2006). Monocyte chemoattractant protein-1 promotes the development of diabetic renal injury in streptozotocin-treated mice. Kidney Int. 69, 73-80.
8. Cornell, L. D., Smith, R. N. and Colvin, R. B. (2008). Kidney transplantation: mechanisms of rejection and acceptance. Annu. Rev. Pathol. 3, 189-220.
9. de Groot, K., Kuklik, K., Brocker, V., Schwarz, A., Gwinner, W., Kreipe, H., Haller, H., Fliser, D. and Mengel, M. (2008). Toll-like receptor 2 and renal allograft function. Am. J. Nephrol. 28, 583-588.
10. El Kasmi, K. C., Qualls, J. E., Pesce, J. T., Smith, A. M., Thompson, R. W., Henao-Tamayo, M., Basaraba, R. J., Konig, T., Schleicher, U., Koo, M. S. et al. (2008). Tolllike receptor-induced arginase 1 in macrophages thwarts effective immunity against intracellular pathogens. Nat. Immunol. 9, 1399-1406.
11. Fuentes, M. E., Durham, S. K., Swerdel, M. R., Lewin, A. C., Barton, D. S., Megill, J. R., Bravo, R. and Lira, S. A. (1995). Controlled recruitment of monocytes and macrophages to specific organs through transgenic expression of monocyte chemoattractant protein-1. J. Immunol. 155, 5769-5776.
12. Girlanda, R., Kleiner, D. E., Duan, Z., Ford, E. A., Wright, E. C., Mannon, R. B. and Kirk, A. D. (2008). Monocyte infiltration and kidney allograft dysfunction during acute rejection. Am. J. Transplant. 8, 600-607.
13. Goldstein, D. (2006). Role of MyD88 and Trif in acute allograft rejection: glass half full or empty? Eur. J. Immunol. 36, 2820.
14. Goldstein, D. R., Tesar, B. M., Akira, S. and Lakkis, F. G. (2003). Critical role of the Toll-like receptor signal adaptor protein MyD88 in acute allograft rejection. J. Clin. Invest. 111, 1571-1578.
15. Goriely, S. and Goldman, M. (2007). The interleukin-12 family: new players in transplantation immunity? Am. J. Transplant. 7, 278-284.
16. Hazeki, K., Nigorikawa, K. and Hazeki, O. (2007). Role of phosphoinositide 3-kinase in innate immunity. Biol. Pharm. Bull. 30, 1617-1623.
17. Hewitson, T. D. (2009). Renal tubulointerstitial fibrosis: common but never simple. Am. J. Physiol. Renal. Physiol. 296, F1239-F1244.
18. Hoffman, E. S., Smith, R. E. and Renaud, R. C., Jr (2005). From the analyst's couch: TLR-targeted therapeutics. Nat. Rev. Drug Discov. 4, 879-880.
19. Iwasaki, A. and Kelsall, B. L. (1999). Freshly isolated Peyer's patch, but not spleen, dendritic cells produce interleukin 10 and induce the differentiation of T helper type 2 cells. J. Exp. Med. 190, 229-239.
20. Iwasaki, A. and Medzhitov, R. (2004). Toll-like receptor control of the adaptive immune responses. Nat. Immunol. 5, 987-995.
21. Kaisho, T. and Akira, S. (2001). Dendritic-cell function in Toll-like receptor- and MyD88-knockout mice. Trends Immunol. 22, 78-83.
22. Kawai, T. and Akira, S. (2008). Toll-like receptor and RIG-I-like receptor signaling. Ann. NY Acad. Sci. 1143, 1-20.
23. Kiss, E., Adams, J., Gröne, H. J. and Wagner, J. (2003). Isotretinoin ameliorates renal damage in experimental acute renal allograft rejection. Transplantation 76, 480-489.
24. Kitagawa, K., Wada, T., Furuichi, K., Hashimoto, H., Ishiwata, Y., Asano, M., Takeya, M., Kuziel, W. A., Matsushima, K., Mukaida, N. et al. (2004). Blockade of CCR2 ameliorates progressive fibrosis in kidney. Am. J. Pathol. 165, 237-246.
25. Kruger, B., Krick, S., Dhillon, N., Lerner, S. M., Ames, S., Bromberg, J. S., Lin, M., Walsh, L., Vella, J., Fischereder, M. et al. (2009). Donor Toll-like receptor 4 contributes to ischemia and reperfusion injury following human kidney transplantation. Proc. Natl. Acad. Sci. USA 106, 3390-3395.
26. Leemans, J. C., Stokman, G., Claessen, N., Rouschop, K. M., Teske, G. J., Kirschning, C. J., Akira, S., van der Poll, T., Weening, J. J. and Florquin, S. (2005). Renalassociated TLR2 mediates ischemia/reperfusion injury in the kidney. J. Clin. Invest. 115, 2894-2903.
27. Lloyd, C. M., Dorf, M. E., Proudfoot, A., Salant, D. J. and Gutierrez-Ramos, J. C. (1997). Role of MCP-1 and RANTES in inflammation and progression to fibrosis during murine crescentic nephritis. J. Leukoc. Biol. 62, 676-680.
28. Matzinger, P. (2002). The danger model: a renewed sense of self. Science 296, 301-305.
29. McKay, D., Shigeoka, A., Rubinstein, M., Surh, C. and Sprent, J. (2006). Simultaneous deletion of MyD88 and Trif delays major histocompatibility and minor antigen mismatch allograft rejection. Eur. J. Immunol. 36, 1994-2002.
30. Medzhitov, R., Preston-Hurlburt, P. and Janeway, C. A., Jr (1997). A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388, 394-397.
31. Nankivell, B. J., Borrows, R. J., Fung, C. L., O'Connell, P. J., Allen, R. D. and Chapman, J. R. (2003). The natural history of chronic allograft nephropathy. N. Engl. J. Med. 349, 2326-2333.
32. Palmer, S. M., Burch, L. H., Mir, S., Smith, S. R., Kuo, P. C., Herczyk, W. F., Reinsmoen, N. L. and Schwartz, D. A. (2006). Donor polymorphisms in Toll-like receptor-4 influence the development of rejection after renal transplantation. Clin. Transplant. 20, 30-36.
33. Pasare, C. and Medzhitov, R. (2005). Control of B-cell responses by Toll-like receptors. Nature 438, 364-368.
34. Picard, N., Baum, O., Vogetseder, A., Kaissling, B. and Le Hir, M. (2008). Origin of renal myofibroblasts in the model of unilateral ureter obstruction in the rat. Histochem. Cell Biol. 130, 141-155.
35. Poltorak, A., He, X., Smirnova, I., Liu, M. Y., Van Huffel, C., Du, X., Birdwell, D., Alejos, E., Silva, M., Galanos, C. et al. (1998). Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282, 2085-2088.
36. Quesniaux, V. F. (1992). Interleukins 9, 10, 11 and 12 and kit ligand: a brief overview. Res. Immunol. 143, 385-400.
37. Raes, G., De Baetselier, P., Noel, W., Beschin, A., Brombacher, F. and Hassanzadeh Gh, G. (2002). Differential expression of FIZZ1 and Ym1 in alternatively versus classically activated macrophages. J. Leukoc. Biol. 71, 597-602.
38. Rissoan, M. C., Soumelis, V., Kadowaki, N., Grouard, G., Briere, F., de Waal Malefyt, R. and Liu, Y. J. (1999). Reciprocal control of T helper cell and dendritic cell differentiation. Science 283, 1183-1186.
39. Rossignol, D. P., Wong, N., Noveck, R. and Lynn, M. (2008). Continuous pharmacodynamic activity of eritoran tetrasodium, a TLR4 antagonist, during intermittent intravenous infusion into normal volunteers. Innate Immun. 14, 383-394.
40. Samstein, B., Johnson, G. B. and Platt, J. L. (2004). Toll-like receptor-4 and allograft responses. Transplantation 77, 475-477.
41. Schaefer, L., Hausser, H., Altenburger, M., Ugorcakova, J., August, C., Fisher, L. W., Schaefer, R. M. and Kresse, H. (1998). Decorin, biglycan and their endocytosis receptor in rat renal cortex. Kidney Int. 54, 1529-1541.
42. Schaefer, L., Babelova, A., Kiss, E., Hausser, H. J., Baliova, M., Krzyzankova, M., Marsche, G., Young, M. F., Mihalik, D., Gotte, M. et al. (2005). The matrix component biglycan is proinflammatory and signals through Toll-like receptors 4 and 2 in macrophages. J. Clin. Invest. 115, 2223-2233.
43. Seki, E., De Minicis, S., Osterreicher, C. H., Kluwe, J., Osawa, Y., Brenner, D. A. and Schwabe, R. F. (2007). TLR4 enhances TGF-beta signaling and hepatic fibrosis. Nat. Med. 13, 1324-1332.
44. Shigeoka, A. A., Holscher, T. D., King, A. J., Hall, F. W., Kiosses, W. B., Tobias, P. S., Mackman, N. and McKay, D. B. (2007). TLR2 is constitutively expressed within the kidney and participates in ischemic renal injury through both MyD88-dependent and -independent pathways. J. Immunol. 178, 6252-6258.
45. Tesar, B. M., Zhang, J., Li, Q. and Goldstein, D. R. (2004). TH1 immune responses to fully MHC mismatched allografts are diminished in the absence of MyD88, a toll-like receptor signal adaptor protein. Am. J. Transplant. 4, 1429-1439.
46. Tesch, G. H. (2008). MCP-1/CCL2: a new diagnostic marker and therapeutic target for progressive renal injury in diabetic nephropathy. Am. J. Physiol. Renal Physiol. 294, F697-F701.
47. Vielhauer, V., Anders, H. J., Mack, M., Cihak, J., Strutz, F., Stangassinger, M., Luckow, B., Grone, H. J. and Schlondorff, D. (2001). Obstructive nephropathy in the mouse: progressive fibrosis correlates with tubulointerstitial chemokine expression and accumulation of CC chemokine receptor 2- and 5-positive leukocytes. J. Am. Soc. Nephrol. 12, 1173-1187.
48. Walker, W. E., Nasr, I. W., Camirand, G., Tesar, B. M., Booth, C. J. and Goldstein, D. R. (2006). Absence of innate MyD88 signaling promotes inducible allograft acceptance. J. Immunol. 177, 5307-5316.
49. Wang, T., Chen, L., Ahmed, E., Ma, L., Yin, D., Zhou, P., Shen, J., Xu, H., Wang, C. R., Alegre, M. L. et al. (2008). Prevention of allograft tolerance by bacterial infection with Listeria monocytogenes. J. Immunol. 180, 5991-5999.
50. Watanabe, A., Hashmi, A., Gomes, D. A., Town, T., Badou, A., Flavell, R. A. and Mehal, W. Z. (2007). Apoptotic hepatocyte DNA inhibits hepatic stellate cell chemotaxis via toll-like receptor 9. Hepatology 46, 1509-1518.
51. Wu, H., Chen, G., Wyburn, K. R., Yin, J., Bertolino, P., Eris, J. M., Alexander, S. I., Sharland, A. F. and Chadban, S. J. (2007). TLR4 activation mediates kidney ischemia/reperfusion injury. J. Clin. Invest. 117, 2847-2859.
52. Zhai, Y., Meng, L., Gao, F., Wang, Y., Busuttil, R. W. and Kupiec-Weglinski, J. W. (2006). CD4+ T regulatory cell induction and function in transplant recipients after CD154 blockade is TLR4 independent. J. Immunol. 176, 5988-5994.
53. Zhang, Z., Schlachta, C., Duff, J., Stiller, C., Grant, D. and Zhong, R. (1995). Improved techniques for kidney transplantation in mice. Microsurgery 16, 103-109.